Literature DB >> 27438538

Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic.

D S Goldberg1,2,3, E Blumberg4, M McCauley2, P Abt5, M Levine5.   

Abstract

Death rates from drug overdoses have nearly doubled since 2003, with over 47 000 deaths in 2014. This is largely attributable to the opioid epidemic. If the unfortunate deaths of otherwise healthy people have yielded an increase in organ donors, then this might serve as perhaps the only comforting factor among this tragic and unnecessary loss of life. In this viewpoint, we present data from the Organ Procurement and Transplantation Network (OPTN) that show how the greatest relative increases in the mechanism of death among deceased donors from 2003 to 2014 were drug overdoses. Unfortunately, despite the absolute increase in the number of donors who died from a drug overdose, the mean organ yield was significantly lower than in other categories, in part due to concerns about disease transmission. In this paper, we present data on the changes in donation from donors with a drug overdose as a result of the opioid epidemic and discuss the need to educate transplant candidates and their physicians about the low risk of disease transmission compared to the greater risk of dying on a transplant waitlist. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  donors and donation; donors and donation: deceased; editorial/personal viewpoint; ethics and public policy; organ procurement and allocation

Mesh:

Year:  2016        PMID: 27438538      PMCID: PMC5462444          DOI: 10.1111/ajt.13971

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  OPTN/SRTR 2012 Annual Data Report: heart.

Authors:  M Colvin-Adams; J M Smithy; B M Heubner; M A Skeans; L B Edwards; C Waller; M A Schnitzler; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

2.  OPTN/SRTR 2013 Annual Data Report: kidney.

Authors:  A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

3.  Changing the paradigm of organ utilization from PHS increased-risk donors: an opportunity whose time has come?

Authors:  Lena Sibulesky; Imran Javed; Jorge D Reyes; Ajit P Limaye
Journal:  Clin Transplant       Date:  2015-07-23       Impact factor: 2.863

4.  OPTN/SRTR 2011 Annual Data Report: liver.

Authors:  W R Kim; P G Stock; J M Smith; J K Heimbach; M A Skeans; E B Edwards; A M Harper; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2013-01       Impact factor: 8.086

5.  Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States.

Authors:  K Ellingson; D Seem; M Nowicki; D M Strong; M J Kuehnert
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

6.  Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.

Authors:  A Suryaprasad; S V Basavaraju; S N Hocevar; N Theodoropoulos; R A Zuckerman; T Hayden; J C Forbi; D Pegues; M Levine; S I Martin; M J Kuehnert; E A Blumberg
Journal:  Am J Transplant       Date:  2015-05-05       Impact factor: 8.086

7.  Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.

Authors:  Michael Green; Shandie Covington; Sarah Taranto; Cameron Wolfe; Walter Bell; Scott W Biggins; David Conti; G David DeStefano; Edward Dominguez; Donna Ennis; Thomas Gross; Mary Klassen-Fischer; Camille Kotton; Dianne LaPointe-Rudow; Yuk Law; Kristen Ludrosky; Marilyn Menegus; Michele I Morris; Michael A Nalesnik; Martha Pavlakis; Timothy Pruett; Costi Sifri; Daniel Kaul
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

8.  OPTN/SRTR 2012 Annual Data Report: lung.

Authors:  M Valapour; M A Skeans; B M Heubner; J M Smith; M A Schnitzler; M I Hertz; L B Edwards; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

  8 in total
  49 in total

Review 1.  Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.

Authors:  Kimberly E Daniel; Adnan Said
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

2.  Trends in deceased donor liver enzymes prior to transplant: The impact on graft selection and outcomes.

Authors:  Melissa G Kaltenbach; Michael O Harhay; Peter L Abt; David S Goldberg
Journal:  Am J Transplant       Date:  2019-09-24       Impact factor: 8.086

3.  The Opioid Crisis and Its Consequences.

Authors:  Scott G Weiner; Sayeed K Malek; Christin N Price
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  The kidney allocation system does not appropriately stratify risk of pediatric donor kidneys: Implications for pediatric recipients.

Authors:  S M Nazarian; A W Peng; B Duggirala; M Gupta; T Bittermann; S Amaral; M H Levine
Journal:  Am J Transplant       Date:  2017-09-15       Impact factor: 8.086

5.  Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival.

Authors:  J B Cohen; J Shults; D S Goldberg; P L Abt; D L Sawinski; P P Reese
Journal:  Am J Transplant       Date:  2017-09-02       Impact factor: 8.086

6.  Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.

Authors:  Ricardo M La Hoz; Burhaneddin Sandıkçı; Venkatesh K Ariyamuthu; Bekir Tanriover
Journal:  Am J Transplant       Date:  2019-08-07       Impact factor: 8.086

7.  Trends in deceased organ donation in Canada.

Authors:  Sam D Shemie
Journal:  CMAJ       Date:  2017-09-25       Impact factor: 8.262

8.  Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States.

Authors:  George Cholankeril; Andrew A Li; Rosann Cholankeril; Alice E Toll; Jeffrey S Glenn; Aijaz Ahmed
Journal:  J Gen Intern Med       Date:  2018-09       Impact factor: 5.128

9.  Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

Authors:  Deirdre Sawinski; Kimberly A Forde; Vincent Lo Re; David S Goldberg; Jordana B Cohen; Jayme E Locke; Roy D Bloom; Colleen Brensinger; Joe Weldon; Justine Shults; Peter P Reese
Journal:  Am J Kidney Dis       Date:  2019-01-29       Impact factor: 8.860

10.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.